Prescribing in borderline personality disorder – the clinical guidelines-Reference-Cited by-同舟云学术

Prescribing in borderline personality disorder – the clinical guidelines

Published:2020-04 Issue:2 Volume:24 Page:25-30
ISSN:1367-7543
Container-title:Progress in Neurology and Psychiatry
language:en
Short-container-title:Prog. Neurol. Psychiatry

Author:

Yadav Devender¹

Affiliation:

1. Dr Yadav is Associate Specialist in General Adult Psychiatry, and Approved Clinician, Heatherwood Court Hospital Pontypridd UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical),Neurology,Pshychiatric Mental Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pnp.667

Reference23 articles.

1. Borderline Personality Disorder

2. American Psychiatric Association (APA).Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Washington (DC): APA 2013.

3. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines

4. Prospective Follow-up Study of Borderline Personality Disorder: Prognosis, Prediction of Outcome, and Axis II Comorbidity

5. American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder (https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bpd.pdf;accessed 4 March 2020).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG);Case Studies: Stahl's Essential Psychopharmacology;2024-04-30

2. Prediction of antipsychotics efficacy based on a polygenic risk score: a real-world cohort study;Frontiers in Pharmacology;2024-03-08

3. Pharmacologic Management of Reproductive Psychopathology;Tasman’s Psychiatry;2024

4. Pharmacologic and non-pharmacologic interventions for emotional lability: A meta-analysis;Neuroscience & Biobehavioral Reviews;2023-06

5. Gulf between research evidence and clinical reality in relation to prescribing in EUPD;Progress in Neurology and Psychiatry;2023-04